As shown in Figure 1A, hepatic CCN2 expression was significantly induced in NAFLD patients with F3–F4 fibrosis compared to those with F0–F1 fibrosis. The gene discussed is CCN2; the disease is metabolic dysfunction-associated steatotic liver disease.